2018
DOI: 10.1093/eurheartj/ehy563.p3671
|View full text |Cite
|
Sign up to set email alerts
|

P3671Myocardial regeneration strategy using Wharton's jelly multipotent stem cells as an “unlimited” therapeutic agent: 3-year outcomes in a pilot cohort of circulate-acute myocardial infarction trial

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles